Evidence map›Paper›PMID 17145739›Full record

ReviewGut2007

Bone marrow stem cells and liver disease.

Y N Kallis, M R Alison, S J Forbes

Registry-linked trialAbstract readReview
In one paragraph

Review in Gut, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT01741090 (The Evaluation of Effectiveness and Safety for New Therapy With Bone Marrow Derived Autologous Mesenchymal Stem Cell for Hepatic Failure Caused by Alcoholic Liver Cirrhosis), which is not on this map. Cited by 46 papers.

0numbers the graph read from it
0cells of the map it votes in
46citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT01741090 phase2unknown statusnot on this mapstarted 2009, after this paper: background citation

The Evaluation of Effectiveness and Safety for New Therapy With Bone Marrow Derived Autologous Mesenchymal Stem Cell for Hepatic Failure Caused by Alcoholic Liver Cirrhosis

TypeinterventionalSponsorYonsei UniversityRan2009 to 2013Enrolled12ConditionsAlcoholic Liver CirrhosisArmsmesenchymal stem cell injection
3 · Its place in the literature

Who cites it

46 citing papers in PubMed.

  1. Trial
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Current Perspectives Regarding Stem Cell-Based Therapy for Liver Cirrhosis.Canadian journal of gastroenterology & hepatology · 2018
    Review
  10. Article
  11. Article
  12. Review
  13. Article
  14. Review
  15. Acute-on-chronic liver failure: terminology, mechanisms and management.Nature reviews. Gastroenterology & hepatology · 2016
    Review
  16. Article
  17. Review
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

3 authors.

Y N KallisDepartment of Medicine, St Mary's Hospital Campus, Imperial College, London, UK. stuart.forbes@ed.ac.uk
M R Alison
S J Forbes

Funding

Medical Research Council G0500428
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AnimalsCell DifferentiationCell MovementClinical Trials as TopicHematopoietic Stem CellsHematopoietic Stem Cell TransplantationHepatocytesHumansLiver DiseasesLiver Regeneration

Identifiers

PMID17145739
PMCPMC1942133

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.